1st half day 2nd half day dash 1st half month 2nd half month dash 1st digit year 2nd digit year 3rd digit year last digit year
Tamiflu Is Still No.1 Drug

Written by Stuart Stevens | Friday, 31 August 2007 | There are 0 comments

the quicker they get their hands on it the more likely they are to live.

The World Health Organisation has reconfirmed that the influenza drug Tamiflu is the drug of choice when trying to treat people who have been infected with the avian flu virus.  The statement that was put on to the World Health Organisation web site explains that people who use the Tamiflu drug are far more likely to survive the symptoms of the virus and that the quicker they get their hands on it the more likely they are to live.

Tamiflu Is Still No.1 Drug

The official figures from the World Health Organisation confirm that the H5N1 bird flu virus has actually infected 321 people around the world and has caused 194 deaths. These are the official figures which have been all verified by scientists working for the World Health Organisation but it is likely that other people have died from the deadly virus and the World Health Organisation is just not aware of these cases. 

The World Health Organisation also issued a number of recommendations which they feel could help in the management of a bird flu pandemic. They said that the cooperation between hospitals in different countries needed to be improved so that clinical information was shared and all doctors understood the disease and how to treat it better.

They also said that more work needed to be done with the Tamiflu drug to see whether to giving larger doses over a longer time could help to improve the survival numbers of people who contract the virus. They also speculated on the possibility that Tamiflu might work well in combination with other flu drugs and suggested that more study was done in this area.

The Tamiflu drug has been used in bird flu cases for a number of years now and is an extremely well known and talked about drug.  Tamiflu is made by the Swiss drug company Roche.

© 2009 This content has been exclusively written by UKMedix [request source information]
ChatterBack with UKMedixGoto ChatterBack with UKMedix

There are 0 comments on this article.

Name :  *
Comment :  *
  Secure Image
Code :  * (please enter the code above)
 

Fields marked with  * are required.